Vincerx Pharma Valuation
| VINC Stock | USD 0.63 0.09 12.50% |
Vincerx Pharma is overvalued. Vincerx Pharma has a current Real Value of $0.6 per share. The regular price of the company is $0.63. Our model measures the value of Vincerx Pharma from inspecting the company fundamentals such as Return On Equity of -1.42, shares outstanding of 30.88 M, and Shares Owned By Institutions of 36.00 % as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Vincerx Pharma's price fluctuation is out of control at this time. Calculation of the real value of Vincerx Pharma is based on 3 months time horizon. Increasing Vincerx Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Vincerx Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Vincerx Stock. However, Vincerx Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.63 | Real 0.6 | Hype 0.63 | Naive 0.85 |
The real value of Vincerx Stock, also known as its intrinsic value, is the underlying worth of Vincerx Pharma Company, which is reflected in its stock price. It is based on Vincerx Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Vincerx Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Vincerx Pharma helps investors to forecast how Vincerx stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Vincerx Pharma more accurately as focusing exclusively on Vincerx Pharma's fundamentals will not take into account other important factors: Vincerx Pharma Total Value Analysis
Vincerx Pharma is at this time estimated to have valuation of (6.59 M) with market capitalization of 10.48 M, debt of 2.5 M, and cash on hands of 80.86 M. The negative valuation of Vincerx Pharma may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Vincerx Pharma fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(6.59 M) | 10.48 M | 2.5 M | 80.86 M |
Vincerx Pharma Asset Utilization
One of the ways to look at asset utilization of Vincerx is to check how much profit was generated for every dollar of assets it reports. Vincerx Pharma has a negative utilization of assets of -0.66 %, losing $0.006599 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Vincerx Pharma shows how discouraging it operates for each dollar spent on its assets.Vincerx Pharma Ownership Allocation
Vincerx Pharma shows a total of 30.88 Million outstanding shares. 30% of Vincerx Pharma outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Vincerx Pharma Profitability Analysis
Net Loss for the year was (40.16 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Vincerx Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Vincerx Pharma and how it compares across the competition.
About Vincerx Pharma Valuation
The stock valuation mechanism determines Vincerx Pharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of Vincerx Pharma. We calculate exposure to Vincerx Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Vincerx Pharma's related companies.Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Vincerx Pharma, Inc. was founded in 2019 is headquartered in Palo Alto, California. Vincera Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 56 people.
Vincerx Pharma Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 21.3 M |
Complementary Tools for Vincerx Stock analysis
When running Vincerx Pharma's price analysis, check to measure Vincerx Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vincerx Pharma is operating at the current time. Most of Vincerx Pharma's value examination focuses on studying past and present price action to predict the probability of Vincerx Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vincerx Pharma's price. Additionally, you may evaluate how the addition of Vincerx Pharma to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |